The landscape of HIV (Human Immunodeficiency Virus) research has been an evolving one, with remarkable strides made over the past decades. However, the quest… Read More »Mice are not men and yet… Challenging the Status Quo: Why CD34+ Humanized Mice Are Dethroning Non-Human Primates in HIV Research
Novel immuno-oncology treatments show great promise in treating cancers. But with approximately 95% of oncological drugs that have shown efficacy in preclinical studies failing… Read More »Maximize your immuno-oncology study potential with the right mouse model
TransCure bioServices’ CEO Patrick Nef shares his thoughts on what the changes will mean for drug development In December 2022, the U.S. House of… Read More »The FDA removes animal testing requirement for drug candidates
The drug development process is long and expensive, taking up to 15 years and costing $1.1 billion for the average drug. Shorter timelines are… Read More »How does your preclinical mouse model affect drug development timelines?
The immune system plays a powerful role in many pathologies including cancer, inflammatory and autoimmune diseases, but it is not fully understood. To develop… Read More »Everything You Need to Know About Humanized Mouse Models
